High-resolution melting analysis, a simple and effective method for reliable mutation scanning and frequency studies in the ACADVL gene.

J Inherit Metab Dis 2010 Jun 18;33(3):247-60. Epub 2010 May 18.

Research Unit for Molecular Medicine, Aarhus University Hospital, Skejby, Brendstrupgaardsvej, Aarhus N, Denmark.

Expanded newborn screening uses tandem mass spectrometry (MS/MS) to identify patients affected with fatty acid oxidation defects by the presence of pathological acylcarnitine esters. A caveat to MS/MS assessment is that cut-off values for disease-specific acylcarnitines does not always clearly discriminate affected patients from carriers and healthy individuals. Diagnostic evaluation of screening-positive samples is required to confirm a metabolic deficiency. With MS/MS newborn screening becoming established in a growing number of countries, streamlined means for time- and -effective follow-on diagnostic evaluation is essential. Moreover, studies to evaluate the diagnostic accuracy of MS/MS newborn screening are needed for determination and adjustment of precise cut-off values for the disease-specific acylcarnitines. In the current study, we use the fatty acid oxidation disorder very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD), the second most common fatty acid oxidation disorder detected by expanded newborn screening, to demonstrate accurate and fast diagnostic evaluation of the ACADVL gene utilizing DNA extracted from the newborn screening dried blood spot and high resolution melt (HRM) profiling. We also demonstrate that HRM is a very effective means to determine carrier frequency of prevalent ACADVL mutations in the general population. Based on estimates of the expected disease incidence, we discuss the diagnostic accuracy of MS/MS-based newborn screening to identify VLCADD in Denmark.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10545-010-9101-yDOI Listing
June 2010
3 Reads

Publication Analysis

Top Keywords

newborn screening
24
acid oxidation
12
diagnostic evaluation
12
fatty acid
12
ms/ms newborn
8
expanded newborn
8
diagnostic accuracy
8
acadvl gene
8
disease-specific acylcarnitines
8
cut-off values
8
values disease-specific
8
oxidation disorder
8
screening
6
newborn
6
diagnostic
5
acylcarnitines current
4
current study
4
study fatty
4
precise cut-off
4
adjustment precise
4

References

(Supplied by CrossRef)

BS Andresen et al.
Am J Hum Genet 1999

A Boneh et al.
Mol Genet Metab 2006

MF Browning et al.
J Inherit Metab Dis 2005

GF Cox et al.
J Pediatr 1998

SF Dobrowolski et al.
Hum Mutat 2005

SF Dobrowolski et al.
Mol Genet Metab 2007

SF Dobrowolski et al.
Hum Mutat 2009

M Erali et al.
Exp Mol Pathol 2008

N Gregersen et al.
Hum Mutat 2001

CN Gundry et al.
Clin Chem 2003

CN Gundry et al.
Nucleic Acids Res 2008

Similar Publications